Search Results 591-600 of 17847 for Coagulation

1. A Study to Evaluate the Effects of N-Acetyl-L-Leucine for GM2 Gangliosdisosis (Tay-Sachs and Sandhoff Disease) - Mayo Clinic

   Known clinically-significant (at the discretion of the investigator) laboratories in hematology, coagulation, clinical chemistry, or urinalysis, including, but ...

2. Rohit R. Rao, M.B.B.S., M.D. - Doctors and Medical Staff - Mayo Clinic

   Hemostasis and Thrombosis Research Society Fellow Grant 2014, Coagulation Workshop.Hemostasis and Thrombosis Research Society. 2014. James J Reilly Leadership ...

3. A Study to Evaluate N-Acetyl-L-Leucine for Niemann-Pick Disease, Type C (NPC) - Mayo Clinic

   Known clinically-significant (at the discretion of the investigator) laboratories in hematology, coagulation, clinical chemistry, or urinalysis, including, but ...

4. A Randomized Phase 3 Trial of TRC105 and Pazopanib Versus Pazopanib Alone in Patients with Advanced Angiosarcoma (TAPPAS) - Mayo Clinic

   Deep venous thrombosis within 3 months prior to randomization unrelated to a central venous catheter, unless the patient is anti-coagulated without the use of ...

5. A Study to Evaluate Proton Therapy for Cardiac Arrhythmias - Mayo Clinic

   Contraindication to appropriate anti-coagulation therapy after ablation. Renal failure requiring dialysis. Prior therapeutic radiation therapy to the left ...

6. (Z)-Endoxifen For The Treatment Of Premenopausal Women With ER+/HER2- Breast Cancer - Mayo Clinic

   Known activated protein C (APC) resistance, an inherited coagulation disorder 4. End stage kidney disease requiring dialysis 5. Evidence of the following ...

7. Dasatinib and Bevacizumab in Treating Patients With Recurrent or Progressive High-Grade Glioma or Glioblastoma Multiforme - Mayo Clinic

   Therapeutic anti-coagulation with low molecular weight heparin is allowed at time of registration. Evidence of bleeding diathesis (greater than normal risk ...

8. https://www.mayoclinic.org/~/media/FD382661FD544C6CB4A38FC785855FAB

9. Coarctation of the aorta - Doctors and departments - Mayo Clinic

   This heart condition is usually present at birth. It's treatable but requires lifelong health checkups. Learn about the causes and treatment.

10. Bevacizumab with or without Anti-Endoglin Monoclonal Antibody TRC105 in Treating Patients with Recurrent Glioblastoma Multiforme - Mayo Clinic

    ... coagulation or any hemorrhage/bleeding event > grade 3 within 4 weeks prior to registration. All patients will have PT/PTT/INR at baseline. Patients on full ...